In this episode of the Huberman Lab podcast, Andrew Huberman interviews Dr. Sergiu Pasca about autism, schizophrenia, and human brain development. The discussion covers the rising prevalence of autism, its genetic components, and novel treatments for profound autism using organoids and assembloids—human brain circuits derived from stem cells. Dr. Pasca explains how these models are used to understand psychiatric illnesses and develop cures, while also addressing ethical considerations related to stem cell therapies and genetic testing. They explore the challenges in defining and treating autism, the role of genetics versus environmental factors, and the potential of gene therapy and CRISPR technology.
Outlines
Part 1: Autism - Introduction and Prevalence
Part 2: Challenges in Autism Research
Part 3: Gene Therapy and Ethical Considerations
Part 4: Stem Cells and iPSCs
Part 5: Organoids and Assembloids
Part 6: Ethical and Practical Considerations of Advanced Models
Part 7: Genetic Testing and Disease Modeling
Part 8: Societal Impact and Closing
Sign in to continue reading, translating and more.